Q&A: From ATTRACT to C-TRACT to PE-TRACT – how three IR-led landmark trials will define Venous Thromboembolism care and elevate our specialty

Monday, March 6, 2023

12:30 PM – 1:00 PM

Location: SIR Central

Moderator(s)

Akhilesh Sista, MD

Professor
Weill Cornell Medicine

Disclosure(s): No financial relationships to disclose
SV

Suresh Vedantham, MD (he/him/his)

Professor and Assistant Dean
Mallinckrodt Institute of Radiology

Disclosure(s): Medi USA: In kind research support (non-financial) (Ongoing)

Panelist(s)

Yogen Kanthi, MD (he/him/his)

Lasker Investigator
National Heart, Lung & Blood Institute

Disclosure(s): No financial relationships to disclose
Julie Mackel, BS (she/her/hers)

Biomedical Engineer
FDA

Disclosure(s): No financial relationships to disclose
RR

Rita F. Redberg, MD, MS

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Akhilesh Sista, MD: No financial relationships to disclose

Suresh Vedantham, MD: Medi USA: In kind research support (non-financial) (Ongoing)

Yogen Kanthi, MD: No financial relationships to disclose

Julie Mackel, BS: No financial relationships to disclose

Rita F. Redberg, MD, MS: No financial relationships to disclose

Following the Plenary Session, attendees will have the opportunity to interact directly with the presenters to discuss compelling issues that relate to pivotal trials of deep vein thrombosis, pulmonary embolism, and post-thrombotic syndrome. Contemporary issues in clinical trial design, how to ensure success in IR-led trials, regulatory agencies' perspectives, and the impact of interventional radiologists in the clinical research arena will be discussed.

Learning Objectives:

Name three controversies in the design of clinical trials of venous thromboembolism.
Understand the unique dimension that interventional radiologists bring to the development and conduct of clinical trials of venous thromboembolism.
Name three ways in which the PE-TRACT Trial will enhance insight into the effect of endovascular PE therapies.